Observe Medical ASA announced that Rune Nystad has decided to step down from his role as Chief Executive Officer ("CEO") with immediate effect to embrace new challenges within the Company. Jørgen Mann, the current Chief Commercial Officer ("CCO"), will step in as the interim CEO. Mr. Mann's leadership abilities and deep understanding of the Company's operations make him well-qualified to oversee the Company's strategy and day-to-day management during this period.

Mr. Nystad will transition into the role as Chief Development Officer ("CDO") of the Company, where his extensive experience in product development will be pivotal in driving Observe Medical's strategic and commercial efforts forward.